137 related articles for article (PubMed ID: 9105422)
1. T cells are unresponsive to transgenic MHC class II molecules expressed on pancreatic beta cells.
Pilström B; Böhme J
Scand J Immunol; 1997 Apr; 45(4):361-5. PubMed ID: 9105422
[TBL] [Abstract][Full Text] [Related]
2. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
[TBL] [Abstract][Full Text] [Related]
4. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
5. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
6. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.
Formby B; Miller N
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2438-42. PubMed ID: 2138777
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation.
Smiley ST; Laufer TM; Lo D; Glimcher LH; Grusby MJ
Int Immunol; 1995 Apr; 7(4):665-77. PubMed ID: 7547694
[TBL] [Abstract][Full Text] [Related]
8. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
9. Resistance to cyclophosphamide-induced diabetes in transgenic NOD mice expressing I-Ak.
Tashiro F; Kasuga A; Shimada A; Ishii M; Takei I; Miyazaki T; Yamamura K; Miyazaki J
Autoimmunity; 1994; 17(3):181-8. PubMed ID: 7948602
[TBL] [Abstract][Full Text] [Related]
10. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
[TBL] [Abstract][Full Text] [Related]
11. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
12. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
13. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
Götz J; Eibel H; Köhler G
Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
[TBL] [Abstract][Full Text] [Related]
14. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
[TBL] [Abstract][Full Text] [Related]
15. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
17. Antigen presenting function of class II MHC expressing pancreatic beta cells.
Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
[TBL] [Abstract][Full Text] [Related]
18. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
19. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
20. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
